Workflow
Ultralife(ULBI)
icon
Search documents
Ultralife(ULBI) - 2019 Q2 - Earnings Call Transcript
2019-08-02 19:31
Ultralife Corporation (NASDAQ:ULBI) Q2 2019 Earnings Conference Call August 1, 2019 8:30 AM ET Company Participants Jody Burfening - Investor Relations Mike Popielec - President & Chief Executive Officer Phil Fain - Chief Financial Officer Conference Call Participants Gary Siperstein - Eliot Rose Wealth Management Operator Good day, and welcome to this Ultralife Corporation's Second Quarter 2019 Earnings Release Conference Call. At this time, I'll like to turn the conference over to Jody Burfening. Please g ...
Ultralife(ULBI) - 2019 Q2 - Earnings Call Presentation
2019-08-01 18:34
Ultralife Corporation Investor Presentation Michael D. Popielec PRESIDENT & CEO Philip A. Fain CFO & TREASURER Updated August 1, 2019 1 IMPORTANT REMINDER – FORWARD LOOKING STATEMENTS This presentation may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to ...
Ultralife(ULBI) - 2019 Q2 - Quarterly Report
2019-08-01 11:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 0-20852 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or ot ...
Ultralife(ULBI) - 2019 Q1 - Earnings Call Transcript
2019-05-05 09:04
Ultralife Corp. (NASDAQ:ULBI) Q1 2019 Earnings Conference Call May 2, 2019 8:30 AM ET Company Participants Jody Burfening - Investor Relations Mike Popielec - President and Chief Executive Officer Phil Fain - Chief Financial Officer Conference Call Participants Gary Siperstein - Eliot Rose Wealth Management Operator Good day and welcome to Ultralife Corporation First Quarter 2019 Earnings Release Call. At this time for opening remarks and introductions, I would like to turn the call over to Ms. Jody Burfeni ...
Ultralife(ULBI) - 2019 Q1 - Quarterly Report
2019-05-02 11:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal quarter ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or oth ...
Ultralife(ULBI) - 2018 Q4 - Earnings Call Transcript
2019-02-09 07:31
Ultralife Corp. (NASDAQ:ULBI) Q4 2018 Earnings Conference Call February 7, 2019 10:00 AM ET Company Participants Jody Burfening – Investor Relations, LHA Mike Popielec – President and Chief Executive Officer Phil Fain – Chief Financial Officer Conference Call Participants Gary Siperstein – Eliot Rose Wealth Management Bill Lauber – Sterling Capital Management Operator Good day, and welcome to the Ultralife Corporation Fourth Quarter 2018 Earnings Release Conference Call. At this time, for opening remarks an ...
Ultralife(ULBI) - 2018 Q4 - Earnings Call Presentation
2019-02-07 18:28
Ultralife Corporation Investor Presentation Michael D. Popielec PRESIDENT & CEO Philip A. Fain CFO & TREASURER Updated February 7, 2019 1 IMPORTANT REMINDER – FORWARD LOOKING STATEMENTS This presentation may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation ...
Ultralife(ULBI) - 2018 Q4 - Annual Report
2019-02-07 12:57
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) /X/ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2018 OR / / Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ____________ to ____________ Commission file number 0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Indicate by check mark ...